Suchen Sie nach Informationen zu Gilead-Unternehmenszentrale? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.
Over Gilead’s 35-year history, bold ambitions were set and achieved in the company’s fight against devastating diseases. Learn more about our ongoing journey. Creating a Better, Healthier World. Advancing Global …
https://www.gilead.com/careers/careers-at-gilead
Equal Opportunities . As an equal opportunity employer, Gilead Sciences, Inc. is committed to a diverse workforce. Employment decisions regarding recruitment and selection will be made without discrimination based on race, color, religion, national origin, gender, age, sexual orientation, physical or mental disability, genetic information or characteristic, gender identity …
https://www.gileadsciences.de/en/
At Gilead, we strive to transform and simplify care for people with life-threatening diseases around the world. Our Mission. Recent News. 18 November 2020. Innovations for Patients - This Year's Gilead Grant Program Projects Announced. 23 October 2020. From Nobel Prize to Practical Implementation: Eliminating Hepatitis C as a Goal ...
https://www.gilead.com/about/leadership
BACK TO MAIN MENU Company Statements Gilead Statement on U.S. Supreme Court Overturning Roe v. Wade All Magrolimab Studies Re-Opening for Patient Enrollment in the U.S. Gilead Statement on WHO Recommendation of Veklury® (Remdesivir) and Acceleration of Prequalification Submission Gilead Implements Contract Pharmacy Integrity Initiative for …
https://www.gilead.com/careers/meet-our-employees
Jessica Jirash Gebara. General Manager, Gilead Mexico. Commercial. Location: Mexico City, Mexico. Joined Gilead: February 2022. As the General Manager of our Mexico affiliate, Jessica Jirash Gebara is responsible for driving the company’s strategy in the country, engaging employees and helping increase access to Gilead’s medicines.
https://www.gilead.es/en/
At Gilead, we strive to transform and simplify care for people with life-threatening diseases around the world. Our Mission. Recent News. 4 July 2022. National and International Researchers Debate in the VII Edition of HIBIC Main Novelties in HIV. 27 June 2022. Gilead and FINBA Sign a Collaboration Agreement to Promote R+D, Training and ...
https://www.gilead.com/news-and-press/press-room/press-releases/2022/5/gilead-and-dragonfly-announce-strategic-research-collaboration-to-develop-natural-killer-cell-engagers-in-oncology-and-inflammation
–Gilead to License Exclusive Worldwide Rights to the Investigational Candidate DF7001, a 5T4-Targeting NK Cell Engager for Solid Tumors – – Gilead to Have Options to License Several Additional NK Cell Engager Programs – FOSTER CITY, Calif. & WALTHAM, Mass.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) and Dragonfly Therapeutics today …
Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Gilead-Unternehmenszentrale gefunden haben.
